Your browser doesn't support javascript.
loading
Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein.
Day, Ryan B; Hickman, Julia A; Xu, Ziheng; Katerndahl, Casey Ds; Ferraro, Francesca; Ramakrishnan, Sai Mukund; Erdmann-Gilmore, Petra; Sprung, Robert W; Mi, Yiling; Townsend, R Reid; Miller, Christopher A; Ley, Timothy J.
Affiliation
  • Day RB; Section of Stem Cell Biology, Division of Oncology, Department of Internal Medicine, and.
  • Hickman JA; Section of Stem Cell Biology, Division of Oncology, Department of Internal Medicine, and.
  • Xu Z; Section of Stem Cell Biology, Division of Oncology, Department of Internal Medicine, and.
  • Katerndahl CD; Section of Stem Cell Biology, Division of Oncology, Department of Internal Medicine, and.
  • Ferraro F; Section of Stem Cell Biology, Division of Oncology, Department of Internal Medicine, and.
  • Ramakrishnan SM; Section of Stem Cell Biology, Division of Oncology, Department of Internal Medicine, and.
  • Erdmann-Gilmore P; Division of Endocrinology, Metabolism and Lipid Research, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Sprung RW; Division of Endocrinology, Metabolism and Lipid Research, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Mi Y; Division of Endocrinology, Metabolism and Lipid Research, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Townsend RR; Division of Endocrinology, Metabolism and Lipid Research, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Miller CA; Section of Stem Cell Biology, Division of Oncology, Department of Internal Medicine, and.
  • Ley TJ; Section of Stem Cell Biology, Division of Oncology, Department of Internal Medicine, and.
J Clin Invest ; 134(4)2023 Dec 07.
Article in En | MEDLINE | ID: mdl-38061017
ABSTRACT
Several canonical translocations produce oncofusion genes that can initiate acute myeloid leukemia (AML). Although each translocation is associated with unique features, the mechanisms responsible remain unclear. While proteins interacting with each oncofusion are known to be relevant for how they act, these interactions have not yet been systematically defined. To address this issue in an unbiased fashion, we fused a promiscuous biotin ligase (TurboID) in-frame with 3 favorable-risk AML oncofusion cDNAs (PMLRARA, RUNX1RUNX1T1, and CBFBMYH11) and identified their interacting proteins in primary murine hematopoietic cells. The PMLRARA- and RUNX1RUNX1T1-TurboID fusion proteins labeled common and unique nuclear repressor complexes, implying their nuclear localization. However, CBFBMYH11-TurboID-interacting proteins were largely cytoplasmic, probably because of an interaction of the MYH11 domain with several cytoplasmic myosin-related proteins. Using a variety of methods, we showed that the CBFB domain of CBFBMYH11 sequesters RUNX1 in cytoplasmic aggregates; these findings were confirmed in primary human AML cells. Paradoxically, CBFBMYH11 expression was associated with increased RUNX1/2 expression, suggesting the presence of a sensor for reduced functional RUNX1 protein, and a feedback loop that may attempt to compensate by increasing RUNX1/2 transcription. These findings may have broad implications for AML pathogenesis.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Proteogenomics Limits: Animals / Humans Language: En Journal: J Clin Invest Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Proteogenomics Limits: Animals / Humans Language: En Journal: J Clin Invest Year: 2023 Document type: Article